Continuation Versus Discontinuation of Sodium‐Glucose Cotransporter‐2 Inhibitors and Cardiorenal Outcomes Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Cohort Study With a Target Trial Emulation Framework

Documenti analoghi

• Sodium‐Glucose Cotransporter 2 Inhibitors Use and Adverse Kidney Outcomes in Patients Receiving Contrast Media
  di: Lung‐Chih Li, et al.
  Pubblicazione: (2025)
• Cardiorenal Outcomes of Sodium–Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Mellitus With Nephrotic‐Range Proteinuria: A Multi‐Institutional Target Trial Emulation
  di: Jia‐Jin Chen, et al.
  Pubblicazione: (2026)
• Target Trial Emulations of Sodium‐Glucose Cotransporter 2 Inhibitors in Systemic Lupus Erythematosus
  di: Janet Pope, et al.
  Pubblicazione: (2025)
• A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema
  di: Quinty Bisseling, et al.
  Pubblicazione: (2026)
• Kidney Effects of Finerenone Added to Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease
  di: Qing Yang, et al.
  Pubblicazione: (2026)